HUMA - Humacyte, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$5.58
DETAILS
HIGH:
$10.00
LOW:
$3.00
MEDIAN:
$5.50
CONSENSUS:
$5.58
UPSIDE:
739.48%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | -736.5% |
| EBIT Margin | -1451.6% |
| EBITDA Margin | -1091.2% |
| Operating Margin | -5271.7% |
| Pretax Margin | -2003.6% |
| Cont. Ops Margin | -2003.6% |
| Net Margin | -2003.6% |
| Bottom Line Margin | -2003.6% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 3.69 |
| Quick Ratio | 2.95 |
| Solvency Ratio | -0.296 |
| Cash Ratio | 2.75 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-3.69
Peers avg: 46.3
|
| PEG Ratio | 0.05 |
| Forward PEG | 0.05 |
| Price/Book | 48.86 |
| Price/Sales | 74.54 |
| Price/FCF | -1.43 |
| Price/Op Cash Flow | -1.45 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.5573 |
| Debt/Equity | 20.8575 |
| Debt/Capital | 0.9542 |
| Long-Term Debt/Capital | 0.9194 |
| Financial Leverage | 37.43 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.05 |
| Operating Cash Flow Ratio | -5.718 |
| Operating Cash Flow/Sales | -5154.2% |
| Free Cash Flow/Operating Cash Flow | 100.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -1.98 |
| Interest Coverage | -9.5500 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -1.62 |
| Capital Expenditure Coverage | -118.83 |
| Dividend + Capital Expenditure Coverage | -118.83 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.01 |
| EPS | -0.258 |
| Debt/Share | 0.4811 |
| Cash/Share | 0.32 |
| Book Value/Share | 0.02 |
| Tangible BV/Share | 0.02 |
| Equity/Share | 0.02 |
| Operating Cash Flow/Share | -0.664 |
| Capital Expenditure/Share | 0.006 |
| FCF/Share | -0.670 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.380 |
| Price/Fair Value | 48.86 |
| Debt/Market Cap | 0.2333 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -7.48 |